Cecilia Furlong
Stock Analyst at Morgan Stanley
(1.83)
# 3,246
Out of 4,974 analysts
173
Total ratings
45.21%
Success rate
-1.63%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cecilia Furlong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SGHT Sight Sciences | Maintains: Equal-Weight | $3 → $4 | $3.71 | +7.82% | 16 | Jul 15, 2025 | |
| MDT Medtronic | Maintains: Overweight | $98 → $107 | $92.90 | +15.18% | 10 | Jul 15, 2025 | |
| IRTC iRhythm Technologies | Maintains: Overweight | $160 → $147 | $181.48 | -19.00% | 17 | Jul 15, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Equal-Weight | $115 → $95 | $105.73 | -10.15% | 12 | May 6, 2025 | |
| ISRG Intuitive Surgical | Upgrades: Overweight | $522 → $650 | $466.86 | +39.23% | 13 | Dec 2, 2024 | |
| EMBC Embecta | Maintains: Underweight | $13 → $12 | $14.96 | -19.79% | 12 | Jul 15, 2024 | |
| TMDX TransMedics Group | Maintains: Equal-Weight | $75 → $95 | $104.01 | -8.66% | 12 | Feb 28, 2024 | |
| ALC Alcon | Maintains: Equal-Weight | $78 → $85 | $80.17 | +6.02% | 9 | May 11, 2023 | |
| AORT Artivion | Maintains: Equal-Weight | $14 → $15 | $43.49 | -65.51% | 4 | May 8, 2023 | |
| PODD Insulet | Maintains: Equal-Weight | $325 → $343 | $348.43 | -1.56% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $11 → $14 | $1.74 | +704.60% | 7 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $44 → $48 | $24.42 | +96.56% | 4 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $95 → $102 | $80.94 | +26.02% | 8 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $56 → $58 | $107.22 | -45.91% | 17 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $20 | $15.01 | +33.24% | 5 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $117 → $131 | $80.51 | +62.71% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $117 → $133 | $132.94 | +0.05% | 11 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $270 → $220 | $392.31 | -43.92% | 4 | Jul 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $383 → $378 | $130.70 | +189.21% | 2 | Feb 25, 2022 |
Sight Sciences
Jul 15, 2025
Maintains: Equal-Weight
Price Target: $3 → $4
Current: $3.71
Upside: +7.82%
Medtronic
Jul 15, 2025
Maintains: Overweight
Price Target: $98 → $107
Current: $92.90
Upside: +15.18%
iRhythm Technologies
Jul 15, 2025
Maintains: Overweight
Price Target: $160 → $147
Current: $181.48
Upside: -19.00%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Equal-Weight
Price Target: $115 → $95
Current: $105.73
Upside: -10.15%
Intuitive Surgical
Dec 2, 2024
Upgrades: Overweight
Price Target: $522 → $650
Current: $466.86
Upside: +39.23%
Embecta
Jul 15, 2024
Maintains: Underweight
Price Target: $13 → $12
Current: $14.96
Upside: -19.79%
TransMedics Group
Feb 28, 2024
Maintains: Equal-Weight
Price Target: $75 → $95
Current: $104.01
Upside: -8.66%
Alcon
May 11, 2023
Maintains: Equal-Weight
Price Target: $78 → $85
Current: $80.17
Upside: +6.02%
Artivion
May 8, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $43.49
Upside: -65.51%
Insulet
May 5, 2023
Maintains: Equal-Weight
Price Target: $325 → $343
Current: $348.43
Upside: -1.56%
May 3, 2023
Maintains: Equal-Weight
Price Target: $11 → $14
Current: $1.74
Upside: +704.60%
Apr 28, 2023
Maintains: Equal-Weight
Price Target: $44 → $48
Current: $24.42
Upside: +96.56%
Apr 27, 2023
Maintains: Overweight
Price Target: $95 → $102
Current: $80.94
Upside: +26.02%
Apr 27, 2023
Maintains: Overweight
Price Target: $56 → $58
Current: $107.22
Upside: -45.91%
Feb 23, 2023
Maintains: Equal-Weight
Price Target: $18 → $20
Current: $15.01
Upside: +33.24%
Jan 6, 2023
Maintains: Equal-Weight
Price Target: $117 → $131
Current: $80.51
Upside: +62.71%
Jan 6, 2023
Maintains: Overweight
Price Target: $117 → $133
Current: $132.94
Upside: +0.05%
Jul 15, 2022
Maintains: Equal-Weight
Price Target: $270 → $220
Current: $392.31
Upside: -43.92%
Feb 25, 2022
Maintains: Equal-Weight
Price Target: $383 → $378
Current: $130.70
Upside: +189.21%